Evidence map›Paper›PMID 22496539›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2012

Distinguishing between longevity and buffered-deleterious genotypes for exceptional human longevity: the case of the MTP gene.

Derek M Huffman, Joris Deelen, Kenny Ye, Aviv Bergman, Eline P Slagboom, Nir Barzilai, Gil Atzmon

Open access · greenAbstract readComparative Study
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Genes and Longevity of Lifespan.International journal of molecular sciences · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Four Genome-Wide Association Studies Identify New Extreme Longevity Variants.The journals of gerontology. Series A, Biological sciences and medical sciences · 2017
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Derek M HuffmanDepartment of Medicine, The Albert Einstein College of Medicine of Yeshiva University, New York, NY, USA.
Joris Deelen
Kenny Ye
Aviv Bergman
Eline P Slagboom
Nir Barzilai
Gil Atzmon
Albert Einstein College of Medicine · USLeiden University Medical Center · NLYeshiva University · US

Funding

Stable Isotope and Metabolomics CoreP60DK020541 · NIDDK · YESHIVA UNIVERSITY · PI FLEISCHER, NORMAN S. · 1986 to 2014
$29.8M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
WEIGHT MGT &NUTRITION FOR PRE-/PERIMENOPAUSAL BREAST CANCER SURVIVORSM01RR012248 · NCRR · YESHIVA UNIVERSITY · PI KHAN, UNAB · 1997 to 2008
$18.4M
STATISTICS AND DATA MANAGEMENT COREP01AG027734 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BARZILAI, NIR J · 2007 to 2012
$9.3M
A Systems Methodology for the Biology of AgingR01AG028872 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BERGMAN, AVIV · 2007 to 2011
$1.8M
Peripheral and central IGF-1 action in energy balance and longevity modulation R00AG037574 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HUFFMAN, DEREK MAJOR · 2013 to 2015
$732k
Peripheral versus central IGF-1 action in the modulation of energy balance and loK99AG037574 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI HUFFMAN, DEREK MAJOR · 2011 to 2012
$177k
NCRR NIH HHS M01 RR012248NCRR NIH HHS M01-RR12248NCRR NIH HHS M01RR12248NCRR NIH HHS RR12248NIA NIH HHS AG027734NIA NIH HHS AG028872NIA NIH HHS AG037574NIA NIH HHS P01 AG027734NIA NIH HHS R01 AG028872NIDDK NIH HHS DK20541NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P60 DK020541
6 · The paper itself

Abstract

The single nucleotide polymorphism, rs2866164, in the MTP gene, has been associated with human longevity but has not been validated by subsequent longevity studies. Using our population of Ashkenazi Jews, we find that the MTP CC genotype is significantly overrepresented in centenarians and their offspring, as compared with controls (p < .05). However, when we examined MTP CC genotype frequency pattern with aging, we observed a monotonic decline between ages 55-85 years followed by a dramatic enrichment after age 90 years, forming a U-shape pattern (p < .05). Furthermore, the MTP CC genotype was buffered by three validated longevity genotypes (p < .05). This buffering effect was found to confer an enrichment of the MTP CC genotype in centenarians, whereas their absence in CC controls resulted in poorer survivorship (p < .05). Thus, we conclude that MTP CC is a buffered-deleterious genotype and that assessing genotype frequency across aging is essential for discerning longevity from buffered-deleterious genotypes.

Indexed as

Gene Expression RegulationGenotypeAgedAged, 80 and overAgingAllelesCarrier ProteinsCohort StudiesFemaleGenetics, PopulationHumansJewsLongevityMaleMiddle AgedPedigreeCarrier Proteinsmicrosomal triglyceride transfer protein

Identifiers

PMID22496539
PMCPMC3668387
OpenAlexW2135470714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.